Have a personal or library account? Click to login
Sodium butyrate attenuate hyperglycemia-induced inflammatory response and renal injury in diabetic mice Cover

Sodium butyrate attenuate hyperglycemia-induced inflammatory response and renal injury in diabetic mice

Acta Pharmaceutica
Volume 73 (2023): Issue 1 (March 2023)
By: Man Yan,  Yan-Yan Zhang,  Yue Xi,  Long-Kun Ding,  Chang Sun,  Li-Juan Qu,  Xin Qian,  Jing-Wen Xu,  Wen Sun and  Liang Wu  
Open Access
|Jan 2023

Authors

Man Yan

School of Medicine, Jiangsu University Zhenjiang, Jiangsu, China

Yan-Yan Zhang

Testing Center, Yangzhou University Yangzhou, Jiangsu, China

Yue Xi

School of Medicine, Jiangsu University Zhenjiang, Jiangsu, China

Long-Kun Ding

School of Medicine, Jiangsu University Zhenjiang, Jiangsu, China

Chang Sun

School of Medicine, Jiangsu University Zhenjiang, Jiangsu, China

Li-Juan Qu

Dental Treatment Center, Shanghai Ninth People’s Hospital, China

Xin Qian

School of Medicine, Jiangsu University Zhenjiang, Jiangsu, China

Jing-Wen Xu

Department of Critical Care Medicine, Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, China

Wen Sun

sunwen19851021@163.com

Department of Critical Care Medicine, Jurong Hospital Affiliated to Jiangsu University, Zhenjiang, China

Liang Wu

wlujs@ujs.edu.cn

School of Medicine, Jiangsu University Zhenjiang, Jiangsu, China
DOI: https://doi.org/10.2478/acph-2023-0008 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 121 - 132
Accepted on: Jul 19, 2022
Published on: Jan 24, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
high concentration glucose,
diabetic nephropathy,
butyrate,
inflammation
Related subjects:
Pharmacy,
Pharmacy, other

© 2023 Man Yan, Yan-Yan Zhang, Yue Xi, Long-Kun Ding, Chang Sun, Li-Juan Qu, Xin Qian, Jing-Wen Xu, Wen Sun, Liang Wu, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 73 (2023): Issue 1 (March 2023)Next article